Salih H, Husfeld L, Adam D
Abteilung für Antimikrobielle Therapie und Infektionsimmunologie, Dr. von Haunersches Kinderspital, University of Munich, Germany.
Eur J Med Res. 1997 Dec 31;2(12):507-13.
The influence of heparin on Polymorphonuclear (PMN s) leukocytes was investigated using a new whole-blood cytofluorometric method (patent granted for the test with the number P 4334935.8-41) with Candida albicans and Staphylococcus aureus as test microorganisms. After comparing the effect of equal volumes of two widely used heparins we examined the influence of 5 different heparin-concentrations. Using both yeasts and bacteria, we found a significant, dose-depending decrease of the percentage of phagocyting PMN's and of phagocytized microorganisms as well as of the resulting percentage of PMN s producing respiratory burst along the kinetics. Furthermore we could demonstrate that heparin independently of phagocytosis produces a dose-dependent decrease of burst production of PMN's. Our results indicate that the use of heparins as anticoagulant for immunological investigations as well as clinically with patients under immunosuppressive therapy should be critically reconsidered. This applies even more because due to the evaluated dose-dependent decrease of phagocyte function no boundary for the inhibiting effect can be declared.
使用一种新的全血细胞荧光测定法(该测试已获得专利,专利号为P 4334935.8 - 41),以白色念珠菌和金黄色葡萄球菌作为测试微生物,研究了肝素对多形核白细胞(PMN)的影响。在比较了两种广泛使用的等体积肝素的效果后,我们检测了5种不同肝素浓度的影响。使用酵母和细菌,我们发现随着动力学变化,吞噬PMN的百分比、吞噬的微生物以及产生呼吸爆发的PMN的最终百分比均出现显著的剂量依赖性下降。此外,我们可以证明,肝素独立于吞噬作用,会使PMN的爆发产生呈剂量依赖性下降。我们的结果表明,肝素作为免疫研究的抗凝剂以及在临床上用于免疫抑制治疗患者时,应进行严格的重新评估。这一点更为重要,因为由于所评估的吞噬细胞功能的剂量依赖性下降,无法确定抑制作用的界限。